HEMOGLOBIN OXYGEN THERAPEUTICS LLC — United States · Federal contract register · Supplier record: 2 contracts, all years ($9,670,708 · Aug 2016 – May 2025); $9.6M since January 2024 (1 contract · 1 agency); 12th rank in the line (of 102 suppliers · 1.69%); 3 agencies never served ($516M on the line without HEMOGLOBIN OXYGEN THERAPEUTICS LLC).
Assay record ASY-US-153986J020 · Cite as: Assay Systems, “HEMOGLOBIN OXYGEN THERAPEUTICS LLC in the USAspending register”, https://assay-systems.com/register/us/hemoglobin-oxygen-therapeutics-llc/
2
contracts, all years
$9,670,708 · Aug 2016 – May 2025
$9.6M
since January 2024
1 contract · 1 agency
12th
rank in the line
of 102 suppliers · 1.69%
3
agencies never served
$516M on the line without HEMOGLOBIN OXYGEN THERAPEUTICS LLC
Own record by year
2025 onward
$9.6M
20252026
Who buys from HEMOGLOBIN OXYGEN THERAPEUTICS LLC
since January 2024
1agencies
$9.6Mpaid
100.0%top buyer
Department of Defense100.0%
$9,559,948
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
12thof 102 suppliers
$9,559,948HEMOGLOBIN OXYGEN THERAPEUTICS LLC in the line
1.69%share of the line
18.9%of $50,693,667 spent by Department of Defense
Agencies that buy the line and never bought from HEMOGLOBIN OXYGEN THERAPEUTICS LLC
3agencies
106contracts
$515,561,760since January 2024
Department of Health and Human Services63 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.